2023 annual financial data
Ultragenyx Pharmaceutical 2023 Operating margin
Direct answer
Operating margin was -131.08%.
Operating income was -569,208,000 USD and net income was -606,639,000 USD.
Operating cash flow was -474,806,000 USD.
Get free Ultragenyx Pharmaceutical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 434,249,000 USD
- Operating income
- -569,208,000 USD
- Net income
- -606,639,000 USD
- Operating cash flow
- -474,806,000 USD